{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:19:00Z","timestamp":1752229140269},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11655-020-2722-6","type":"journal-article","created":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T15:03:31Z","timestamp":1587827011000},"page":"16-23","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of Tongguan Capsules (\u901a\u51a0\u80f6\u56ca) on Restenosis after Coronary Stent Implantation: Study Protocol for A Randomized Controlled Trial"],"prefix":"10.1007","volume":"27","author":[{"given":"Yuan-shen","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-heng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong-yi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-zhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"key":"2722_CR1","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1253\/circj.72.1054","volume":"72","author":"K Nomoto","year":"2008","unstructured":"Nomoto K, Watanabe I, Oba T, Nagao K, Kushiro T, Hirayama A. Safety and efficacy of sirolimus-eluting stent in patients with acute coronary syndrome undergoing emergency procedure. Circ J 2008;72:1054\u20131058.","journal-title":"Circ J"},{"key":"2722_CR2","first-page":"173","volume":"15","author":"L Pleva","year":"2018","unstructured":"Pleva L, Kukla P, Hlinomaz O. Treatment of coronary instent restenosis: a systematic review. J Geriatric Cardiol 2018;15:173\u2013184.","journal-title":"J Geriatric Cardiol"},{"key":"2722_CR3","first-page":"e003255","volume":"9","author":"KC Koskinas","year":"2016","unstructured":"Koskinas KC, Siontis GCM, Piccolo R, Franzone A, Haynes A, Rat-Wirtzler J, et al. Impact of diabetic status on outcomes after revascularization with drug-eluting stents in relation to coronary artery disease complexity. Circulation: Cardiovas Intervent 2016;9:e003255.","journal-title":"Circulation: Cardiovas Intervent"},{"key":"2722_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jcin.2016.11.005","volume":"10","author":"M Hiroyoshi","year":"2017","unstructured":"Hiroyoshi Mori, Christoph Lutter, Kazuyuki Yahagi, Emanuel Harari, Aloke VF. Pathology of chronic total occlusion in bare-metal versus drug-eluting stents. JACC Cardiovasc Intervent 2017;10:367\u2013378.","journal-title":"JACC Cardiovasc Intervent"},{"key":"2722_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/MCA.0000000000000109","volume":"25","author":"P Li","year":"2014","unstructured":"Li P, Liu JP. Long-term risk of late and very late stent thrombosis in patients treated with everolimus against paclitaxel-eluting stents: an update meta-analysis. Coronary Artery Dis 2014;25:369\u2013377.","journal-title":"Coronary Artery Dis"},{"key":"2722_CR6","first-page":"722","volume":"75","author":"AR S.Norozi","year":"2017","unstructured":"S.Norozi AR, E.Salimi, H.Tavan. The incidence of major cardiovascular events relied coronary vessels after angioplasty and stent types complications. Tehran Univ Med J 2017;75:722\u2013729.","journal-title":"Tehran Univ Med J"},{"key":"2722_CR7","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/ccd.22431","volume":"75","author":"B Williams","year":"2010","unstructured":"Williams B, Menon M, Satran D, Hayward D, Hodges JS, Burke MN, et al. Patients with coronary artery disease not amenable to traditional revascularization: prevalence and 3-year mortality. Catheter Cardiovasc Interv 2010;75:886\u2013891.","journal-title":"Catheter Cardiovasc Interv"},{"key":"2722_CR8","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1093\/eurheartj\/ehv511","volume":"36","author":"RA Byrne","year":"2015","unstructured":"Byrne RA, Joner M, Kastrati A. Stent thrombosis and restenosis: What have we learned and where are we going? Eur Heart J 2015;36:3320\u20133331.","journal-title":"Eur Heart J"},{"key":"2722_CR9","first-page":"253409","volume":"2012","author":"GH Zheng","year":"2012","unstructured":"Zheng GH, Liu JP, Wang NS, Chen HY, Chu JF. Systematic review of Chinese herbal medicines for preventing instent coronary restenosis after percutaneous coronary intervention. Evid Based Complement Alternat Med eCAM 2012;2012:253409.","journal-title":"Evid Based Complement Alternat Med eCAM"},{"key":"2722_CR10","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/ptr.6057","volume":"32","author":"Z Jihong","year":"2018","unstructured":"Jihong Z, Ke W. Astragaloside IV inhibits TGF-\u03b21-induced epithelial mesenchymal transition through inhibition of the PI3K\/Akt\/NF-\u03baB pathway in gastric cancer cells. Phytother Res Ptr 2018;32:1289\u20131296.","journal-title":"Phytother Res Ptr"},{"key":"2722_CR11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2174\/1381612822666161010105242","volume":"23","author":"W Lili","year":"2017","unstructured":"Lili W, Rufeng M, Chenyue L, Haixia L, Ruyuan Z, Shuzhen G, et al. Salvia miltiorrhiza: A potential red light to the development of cardiovascular diseases. Current Pharmac Design 2017;23:1077\u20131097.","journal-title":"Current Pharmac Design"},{"key":"2722_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ctcp.2009.11.005","volume":"16","author":"AP Singh","year":"2010","unstructured":"Singh AP. Medicinal leech therapy (Hirudotherapy): a brief overview. Complement Therapies Clin Pract 2010;16:213\u2013215.","journal-title":"Complement Therapies Clin Pract"},{"issue":"3","key":"2722_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/FJC.0000000000000403","volume":"68","author":"L Chen","year":"2016","unstructured":"Chen L, Li X, Li C, Rong Y, Zhang M. Chinese Herbal Cardiotonic Pill Stabilizes Vulnerable Plaques in Rabbits by Decreasing the Expression of Adhesion Molecules. J Cardiovasc Pharmac 2016;68(3):1.","journal-title":"J Cardiovasc Pharmac"},{"key":"2722_CR14","first-page":"715790","volume":"2012","author":"X Qiu","year":"2012","unstructured":"Qiu X, Miles A, Jiang X, Sun X, Yang N. Sulfotanshinone sodium injection for unstable angina pectoris: a systematic review of randomized controlled trials. Evid Base Complement Alternat Med 2012;2012:715790.","journal-title":"Evid Base Complement Alternat Med"},{"key":"2722_CR15","first-page":"62","volume":"10","author":"S Mao","year":"2014","unstructured":"Mao S, Wang Y, Zhang M, Hinek A. Phytoestrogen, tanshinone II A diminishes collagen deposition and stimulates elastogenesis in cultures of human cardiac fibroblasts. Exp Cell Res 2014;10:62\u201367.","journal-title":"Exp Cell Res"},{"key":"2722_CR16","first-page":"159237","volume":"2013","author":"J Qi","year":"2013","unstructured":"Qi J, Yu J, Wang L, Guo L, Ma S, Huang D. Tongguan Capsule protects against myocardial ischemia and reperfusion injury in mice. Evid Base Complement Alternat Med 2013;2013:159237.","journal-title":"Evid Base Complement Alternat Med"},{"key":"2722_CR17","first-page":"42","volume-title":"The People\u2019s Republic of China TCM Industry Standards. The standards of diagnosis and efficacy of TCM syndromes","author":"State Administration of Traditional Chinese Medicine.","year":"1994","unstructured":"State Administration of Traditional Chinese Medicine. The People\u2019s Republic of China TCM Industry Standards. The standards of diagnosis and efficacy of TCM syndromes. Nanjing: Nanjing University Press; 1994:42\u201350."},{"key":"2722_CR18","volume-title":"Guiding principle of new drugs of traditional Chinese medicine (Trial Implementation)","author":"XY Zheng","year":"2002","unstructured":"Zheng XY. Guiding principle of new drugs of traditional Chinese medicine (Trial Implementation). Beijing: China Medical Science Press; 2002."},{"key":"2722_CR19","first-page":"1920","volume":"10","author":"K Nanette","year":"2011","unstructured":"Nanette K. Wenger MD. 2011ACCF\/AHA focused update of the guidelines for the management of patients with unstable angina\/non\u2013ST-elevation myocardial infarction (updating the 2007 Guideline). J Am Coll Cardiol 2011;10:1920\u20131959.","journal-title":"J Am Coll Cardiol"},{"key":"2722_CR20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1001\/jamainternmed.2013.12855","volume":"174","author":"K Stergiopoulos","year":"2014","unstructured":"Stergiopoulos K, Boden WE, Hartigan P, Sven M\u00f6biusWinkler, Hambrecht R, Hueb W, et al. Percutaneous coronary intervention meta-analysis. JAMA Intern Med 2014;174:232\u2013240.","journal-title":"JAMA Intern Med"},{"key":"2722_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/CIRCINTERVENTIONS.110.959882","volume":"4","author":"V Farooq","year":"2011","unstructured":"Farooq V, Gogas BD, Serruys PW. Restenosis. Circ Cardiovasc Intervent 2011;4:195.","journal-title":"Circ Cardiovasc Intervent"},{"key":"2722_CR22","first-page":"173","volume":"2","author":"SB Seif-Naraghi","year":"2013","unstructured":"Seif-Naraghi SB, Singelyn JM, Salvatore MA, Osborn KG, Wang JJ, Sampat U, et al. Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. Sci Translat Med 2013;2:173\u2013179.","journal-title":"Sci Translat Med"},{"key":"2722_CR23","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3389\/fphys.2018.00589","volume":"9","author":"S Mao","year":"2018","unstructured":"Mao S, Peipei C, Li T, Guo LH, Zhang MZ. Tongguan Capsule mitigates post-myocardial infarction remodeling by promoting autophagy and inhibiting apoptosis: role of sirt1. Front Phys 2018;9:589.","journal-title":"Front Phys"},{"key":"2722_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5246\/jcps.2018.01.001","volume":"27","author":"W Shen","year":"2018","unstructured":"Shen W, Yu F, Xu L, Chen C, Cao Y, Liu S, et al. Protective effects of tanshinone II a derivative on myocardial ischemia\/ reperfusion injury in rats. J Chin Pharmac Sci 2018;27:1\u201313.","journal-title":"J Chin Pharmac Sci"},{"key":"2722_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.phymed.2009.08.010","volume":"3","author":"Z Ren","year":"2010","unstructured":"Ren Z, Tong Y, Xu W. TanshinoneII A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression. Phytomedicine 2010;3:212\u2013218.","journal-title":"Phytomedicine"},{"key":"2722_CR26","first-page":"12","volume":"3","author":"L Shuang","year":"2011","unstructured":"Shuang L, Lin W. Clinical applications and pharmacological actions of sodium tanshinone II A sulfonate injection. Pharm Clin Chin Mater Med 2011;3:12\u201313.","journal-title":"Pharm Clin Chin Mater Med"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-020-2722-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-020-2722-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-020-2722-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T18:24:24Z","timestamp":1722795864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-020-2722-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2722"],"URL":"https:\/\/doi.org\/10.1007\/s11655-020-2722-6","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"type":"print","value":"1672-0415"},{"type":"electronic","value":"1993-0402"}],"subject":[],"published":{"date-parts":[[2020,4,24]]},"assertion":[{"value":"17 August 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Clinical Research Ethical Committee at Guangdong Provincial Hospital of CM approved the research protocol (B2017-008-01).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Competing Interests","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}}]}}